Shares of Proteome Sciences plc (LON:PRM – Get Free Report) traded down 15.2% during mid-day trading on Tuesday . The company traded as low as GBX 1.40 and last traded at GBX 1.40. 455,574 shares changed hands during trading, an increase of 10% from the average daily volume of 414,862 shares. The stock had previously closed at GBX 1.65.
Proteome Sciences Trading Down 15.2%
The business has a fifty day moving average price of GBX 1.59 and a 200 day moving average price of GBX 1.88. The company has a market capitalization of £4.91 million, a PE ratio of -1.35 and a beta of 0.15. The company has a debt-to-equity ratio of -165.46, a quick ratio of 0.37 and a current ratio of 0.13.
Proteome Sciences (LON:PRM – Get Free Report) last issued its earnings results on Wednesday, April 15th. The company reported GBX (1.04) earnings per share (EPS) for the quarter. The firm had revenue of GBX 376 million for the quarter. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
- Abivax: Wall Street Catches Up to the Data
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
